Jazz Pharmaceuticals Plc - Company Profile
Powered by
All the data and insights you need on Jazz Pharmaceuticals Plc in one report.
- Save hours of research time and resources with
our up-to-date Jazz Pharmaceuticals Plc Strategy Report
- Understand Jazz Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Jazz Pharmaceuticals plc (Jazz Pharmaceuticals) manufactures pharmaceutical products for the treatment of hematological diseases, psychiatric disorders, and cancer. Diversified product portfolio, focus on R&D, and well-established global presence are its strengths even as history of operational losses could be a cause for concern to the company. Jazz Pharmaceuticals could benefit from contracts and agreements, orphan drug designation exclusivity for its products, and market potential for Acute Myeloid Leukemia (AML). However, intense competition, stringent government regulations and dependence on wholesale distributors could hamper the company’s operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer